<! DOCTYPE = html>
<html>
<title>CS657 - Prescription</title>
<style>
div.container {
		width: 100%;
		border: 1px solid gray;
}

header{
		padding: 0.5em;
		#color: black;
		background-color: orange;
		clear: left;
		text-align: center;
}
.footer{
		padding : 1em;
		background-color: orange;
		text-align: center;
		<!--- position: fixed;>
		bottom : 0;
		width : 100%;
}

nav {
		float: left;
		max-width: 160px;
		margin: 0;
		padding: 1em;
}

nav ul {
		list-style-type: none;
		padding: 0;
}
	 
nav ul a {
		text-decoration: none;
}

article {
		margin-left: 170px;
		border-left: 1px solid gray;
		padding: 1em;
		overflow: hidden;
}
table {
		font-family: arial, sans-serif;
		border-collapse: collapse;
		width: 80%;
}

td, th {
		border: 4px solid #000000;
		text-align: middle;
		padding: 8px;
}

tr:nth-child(even) {
		background-color: #eeeeee;
}	

div.box {
		background-color: white;
		width: 300px;
		border: 2px solid green;
		padding: 10px;
		margin: 25px;
}
</style>
<body>
<div class="container">
	<header><h1>
		IIT Kanpur Medical Labs</h1>
	</header>
	<hr>	<h2> Precription for the query: </h2>
	<div class="box">
	cold, fever
	</div>
	<hr>	<h2>
		Identified Disease: </h2>
	<div class="box">
	Bacterial Infections
	</div>
	<hr>	<h2>More Symptoms: </h2>
	<div class="box">
	Cyanosis, Ataxia, Spasm, Headache, Quadriplegia
	</div>
		<hr><h2>
Medication:</h2>
<table>
	<tr>
		<th>Serial No</th>
		<th>Drug Name</th>
		<th>Group</th>
		<th>Indication</th>
	</tr>	<tr>
		<td>1.</td>
		<td>Cefacetrile</td>
		<td>Approved</td>
		<td>Cefacetrile is a broad-spectrum first generation cephalosporin antibiotic effective in Gram-positive and Gram-negative bacterial infections.</td>
	</tr>	<tr>
		<td>2.</td>
		<td>Viomycin</td>
		<td>Approved</td>
		<td>Viomycin is an essential component in the drug cocktail currently used to fight infections of Mycobacterium tuberculosis.</td>
	</tr>	<tr>
		<td>3.</td>
		<td>Cefazolin</td>
		<td>Approved</td>
		<td>Mainly used to treat bacterial infections of the skin. It can also be used to treat moderately severe bacterial infections involving the lung, bone, joint, stomach, blood, heart valve, and urinary tract. It is clinically effective against infections caused by staphylococci and streptococci species of Gram positive bacteria. May be used for surgical prophylaxis; if required metronidazole may be added to cover B. fragilis.</td>
	</tr>	<tr>
		<td>4.</td>
		<td>Dalfopristin</td>
		<td>Approved</td>
		<td>For the treatment of bacterial infections (usually in combination with quinupristin).</td>
	</tr>	<tr>
		<td>5.</td>
		<td>Cefprozil</td>
		<td>Approved</td>
		<td>For the treatment of the following infections (respiratory, skin, soft tissue, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staph</td>
	</tr>	<tr>
		<td>6.</td>
		<td>Teicoplanin</td>
		<td>Approved, Investigational</td>
		<td>For the treatment of bacterial infections caused by susceptible microorganisms.</td>
	</tr>	<tr>
		<td>7.</td>
		<td>Dirithromycin</td>
		<td>Approved, Investigational</td>
		<td>For the treatment of the following mild-to-moderate infections caused by susceptible strains of microorganisms: acute bacterial exacerbations of chronic bronchitis, secondary bacterial infection of acute bronchitis, community-acquired pneumonia, pharyngitis/tonsilitis, and uncomplicated skin and skin structure infections.</td>
	</tr>	<tr>
		<td>8.</td>
		<td>Cefonicid</td>
		<td>Approved, Investigational</td>
		<td>For the treatment of bacterial infections caused by susceptible microorganisms.</td>
	</tr>	<tr>
		<td>9.</td>
		<td>Latamoxef</td>
		<td>Approved, Investigational</td>
		<td>Latamoxef is an oxacephem antibiotic usually grouped with the cephalosporins. It is used to treat bacterial infections. Latamoxef is primarily indicated in conditions like Bone and joint infection, GI infections, Gynecological infections, Meningitis, Respiratory tract infections, Septicaemia, Skin infections, Soft tissue infections, UTI. </td>
	</tr>	<tr>
		<td>10.</td>
		<td>Phenoxymethylpenicillin</td>
		<td>Approved, Vet approved</td>
		<td>For the treatment of mild to moderately severe infections (e.g. dental infection, infections in the heart, middle ear infections, rheumatic fever, scarlet fever, skin infections, upper and lower respiratory tract infections) due to microorganisms.</td>
	</tr>	<tr>
		<td>11.</td>
		<td>Nitrofural</td>
		<td>Approved, Investigational, Vet approved</td>
		<td>For the treatement of bacterial skin infections including pyodermas, infected dermatoses and infections of cuts, wounds, burns and ulcers due to susceptible organisms.</td>
	</tr>	<tr>
		<td>12.</td>
		<td>Iclaprim</td>
		<td>Investigational</td>
		<td>Investigated for use/treatment in bacterial infection, skin infections/disorders, obesity, liver disease, kidney disease, and pneumonia.</td>
	</tr>	<tr>
		<td>13.</td>
		<td>REP8839</td>
		<td>Investigational</td>
		<td>For the treatment of bacterial infections caused by susceptible microorganisms (Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), and Streptococcus pyogenes).</td>
	</tr>	<tr>
		<td>14.</td>
		<td>Garenoxacin</td>
		<td>Investigational</td>
		<td>Investigated for use/treatment in bacterial infection.</td>
	</tr>	<tr>
		<td>15.</td>
		<td>KB001</td>
		<td>Investigational</td>
		<td>For the treatment of infections caused by multi-drug resistant Pseudomonas aeruginosa.</td>
	</tr>	<tr>
		<td>16.</td>
		<td>PA mAb</td>
		<td>Investigational</td>
		<td>Investigated for use/treatment in anthrax exposure and bacterial infection.</td>
	</tr>	<tr>
		<td>17.</td>
		<td>Technetium Tc-99m ciprofloxacin</td>
		<td>Investigational</td>
		<td>Investigated for use/treatment in infectious and parasitic disease (unspecified).</td>
	</tr>	<tr>
		<td>18.</td>
		<td>Gepotidacin</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>19.</td>
		<td>Lanopepden</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>20.</td>
		<td>Omadacycline</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>21.</td>
		<td>Epetraborole</td>
		<td>Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>22.</td>
		<td>ACE393</td>
		<td>Investigational</td>
		<td>Investigated for use/treatment in diarrhea and infectious and parasitic disease (unspecified).</td>
	</tr>	<tr>
		<td>23.</td>
		<td>BG-777</td>
		<td>Investigational</td>
		<td>Investigated for use/treatment in cytomegalovirus (CMV) retinitis, HIV infection, influenza, and pneumonia.</td>
	</tr>	<tr>
		<td>24.</td>
		<td>Cefilavancin</td>
		<td>Investigational</td>
		<td>Investigated for use/treatment in bacterial infection, skin infections/disorders, and staph bacterial infections.</td>
	</tr>	<tr>
		<td>25.</td>
		<td>Loracarbef</td>
		<td>Investigational, Withdrawn</td>
		<td>Used to treat upper respiratory tract bacterial infections, chronic bronchitis, pneumonia, sinusitis, pharyntitis and tonsillitis, skin absceses, urinary tract infections and pyelonephritis caused by E. coli, S. pyogenes, S. aureus, S. saprphyticus, S. penumoniae, H. influenzae and M. catarrhalis.</td>
	</tr></table>
<div class="footer"> Copyright &copy : IIT Kanpur
</div>	
</div>
</body>
</html>